- Home
- PVLA vs DCOM Comparison
PVLA vs DCOM Comparison
Compare PVLA & DCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PVLA | DCOM |
|---|---|---|
| Founded | 2015 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | PVLA | DCOM |
|---|---|---|
| Price | $82.38 | $36.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 5 |
| Target Price | ★ $145.24 | $36.40 |
| AVG Volume (30 Days) | 243.4K | ★ 322.3K |
| Earning Date | 11-11-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.76% |
| EPS Growth | N/A | ★ 329.09 |
| EPS | N/A | ★ 2.36 |
| Revenue | N/A | ★ $409,901,000.00 |
| Revenue This Year | N/A | $21.40 |
| Revenue Next Year | N/A | $12.62 |
| P/E Ratio | ★ N/A | $15.35 |
| Revenue Growth | N/A | ★ 47.45 |
| 52 Week Low | $14.60 | $23.25 |
| 52 Week High | $114.69 | $36.47 |
Technical Indicators
Market Signals| Indicator | PVLA | DCOM |
|---|---|---|
| Relative Strength Index (RSI) | 41.52 | 76.82 |
| Support Level | $74.40 | $35.44 |
| Resistance Level | $83.47 | $36.42 |
| Average True Range (ATR) | 5.91 | 1.30 |
| MACD | -1.09 | 0.33 |
| Stochastic Oscillator | 27.30 | 96.19 |
Price Performance
Historical ComparisonAbout PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.